- Home
- TSBX vs GSUN Comparison
TSBX vs GSUN Comparison
Compare TSBX & GSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBX
- GSUN
- Stock Information
- Founded
- TSBX 2015
- GSUN 1997
- Country
- TSBX United States
- GSUN China
- Employees
- TSBX N/A
- GSUN N/A
- Industry
- TSBX
- GSUN Other Consumer Services
- Sector
- TSBX
- GSUN Real Estate
- Exchange
- TSBX Nasdaq
- GSUN Nasdaq
- Market Cap
- TSBX 7.6M
- GSUN N/A
- IPO Year
- TSBX 2023
- GSUN 2022
- Fundamental
- Price
- TSBX $0.35
- GSUN $3.51
- Analyst Decision
- TSBX Buy
- GSUN
- Analyst Count
- TSBX 3
- GSUN 0
- Target Price
- TSBX $4.75
- GSUN N/A
- AVG Volume (30 Days)
- TSBX 77.6K
- GSUN 14.9K
- Earning Date
- TSBX 05-20-2025
- GSUN 05-20-2025
- Dividend Yield
- TSBX N/A
- GSUN N/A
- EPS Growth
- TSBX N/A
- GSUN N/A
- EPS
- TSBX N/A
- GSUN N/A
- Revenue
- TSBX N/A
- GSUN $10,159,020.00
- Revenue This Year
- TSBX N/A
- GSUN N/A
- Revenue Next Year
- TSBX N/A
- GSUN N/A
- P/E Ratio
- TSBX N/A
- GSUN N/A
- Revenue Growth
- TSBX N/A
- GSUN 65.04
- 52 Week Low
- TSBX $0.29
- GSUN $2.25
- 52 Week High
- TSBX $3.39
- GSUN $9.93
- Technical
- Relative Strength Index (RSI)
- TSBX 48.40
- GSUN 59.07
- Support Level
- TSBX $0.32
- GSUN $3.30
- Resistance Level
- TSBX $0.37
- GSUN $3.70
- Average True Range (ATR)
- TSBX 0.04
- GSUN 0.26
- MACD
- TSBX 0.00
- GSUN 0.03
- Stochastic Oscillator
- TSBX 74.07
- GSUN 65.79
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.